Skip to main content
Clinical Trials/NL-OMON34877
NL-OMON34877
Completed
Phase 4

Patient-controlled remifentanil analgesia (PCA) during oocyte retrieval for IVF/ICSI procedures - RELIEF study

Vrije Universiteit Medisch Centrum0 sites78 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
10013356
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
78
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Female subjects who undergo elective IVF/ICSI
  • \- Age 18\-45 years
  • \- Informed consent

Exclusion Criteria

  • \- Not willing to receive analgesia
  • \- Allergy for remifentanil or pethidine

Outcomes

Primary Outcomes

Not specified

Similar Trials